These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

353 related items for PubMed ID: 3079597

  • 1. Intravenous administration of pulsatile gonadotropin-releasing hormone in hypothalamic amenorrhea: effects of dosage.
    Santoro N, Wierman ME, Filicori M, Waldstreicher J, Crowley WF.
    J Clin Endocrinol Metab; 1986 Jan; 62(1):109-16. PubMed ID: 3079597
    [Abstract] [Full Text] [Related]

  • 2. Even after priming with ovarian steroids or pulsatile gonadotropin-releasing hormone administration, naltrexone is unable to induce ovulation in women with functional hypothalamic amenorrhea.
    Couzinet B, Young J, Brailly S, Chanson P, Schaison G.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2102-7. PubMed ID: 7608262
    [Abstract] [Full Text] [Related]

  • 3. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea.
    Martin KA, Hall JE, Adams JM, Crowley WF.
    J Clin Endocrinol Metab; 1993 Jul; 77(1):125-9. PubMed ID: 8325934
    [Abstract] [Full Text] [Related]

  • 4. Evidence for a specific role of GnRH pulse frequency in the control of the human menstrual cycle.
    Filicori M, Flamigni C, Campaniello E, Ferrari P, Meriggiola MC, Michelacci L, Pareschi A, Valdiserri A.
    Am J Physiol; 1989 Dec; 257(6 Pt 1):E930-6. PubMed ID: 2514600
    [Abstract] [Full Text] [Related]

  • 5. Pulsatile GnRH stimulates normal cyclic ovarian function in amenorrheic lactating postpartum women.
    Zinaman MJ, Cartledge T, Tomai T, Tippett P, Merriam GR.
    J Clin Endocrinol Metab; 1995 Jul; 80(7):2088-93. PubMed ID: 7608260
    [Abstract] [Full Text] [Related]

  • 6. Pulsatile gonadotropin secretion in women with hypothalamic amenorrhea: evidence that reduced frequency of gonadotropin-releasing hormone secretion is the mechanism of persistent anovulation.
    Reame NE, Sauder SE, Case GD, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1985 Nov; 61(5):851-8. PubMed ID: 3900122
    [Abstract] [Full Text] [Related]

  • 7. Endocrine response determines the clinical outcome of pulsatile gonadotropin-releasing hormone ovulation induction in different ovulatory disorders.
    Filicori M, Flamigni C, Meriggiola MC, Ferrari P, Michelacci L, Campaniello E, Valdiserri A, Cognigni G.
    J Clin Endocrinol Metab; 1991 May; 72(5):965-72. PubMed ID: 1902487
    [Abstract] [Full Text] [Related]

  • 8. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH.
    Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):327-33. PubMed ID: 3123511
    [Abstract] [Full Text] [Related]

  • 9. The abnormal response of polycystic ovarian disease patients to exogenous pulsatile gonadotropin-releasing hormone: characterization and management.
    Filicori M, Flamigni C, Campaniello E, Valdiserri A, Ferrari P, Meriggiola MC, Michelacci L, Pareschi A.
    J Clin Endocrinol Metab; 1989 Oct; 69(4):825-31. PubMed ID: 2506216
    [Abstract] [Full Text] [Related]

  • 10. Exaggerated free alpha-subunit levels during pulsatile gonadotropin-releasing hormone replacement in women with idiopathic hypogonadotropic hypogonadism.
    Lavoie HB, Martin KA, Taylor E, Crowley WF, Hall JE.
    J Clin Endocrinol Metab; 1998 Jan; 83(1):241-7. PubMed ID: 9435449
    [Abstract] [Full Text] [Related]

  • 11. Abnormal patterns of pulsatile luteinizing hormone secretion in women with hyperprolactinemia and amenorrhea: responses to bromocriptine.
    Sauder SE, Frager M, Case GD, Kelch RP, Marshall JC.
    J Clin Endocrinol Metab; 1984 Nov; 59(5):941-8. PubMed ID: 6434588
    [Abstract] [Full Text] [Related]

  • 12. The antigonadotropic activity of a 19-nor-progesterone derivative is exerted both at the hypothalamic and pituitary levels in women.
    Couzinet B, Young J, Kujas M, Meduri G, Brailly S, Thomas JL, Chanson P, Schaison G.
    J Clin Endocrinol Metab; 1999 Nov; 84(11):4191-6. PubMed ID: 10566671
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Specific factors predict the response to pulsatile gonadotropin-releasing hormone therapy in polycystic ovarian syndrome.
    Gill S, Taylor AE, Martin KA, Welt CK, Adams JM, Hall JE.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2428-36. PubMed ID: 11397835
    [Abstract] [Full Text] [Related]

  • 15. Is GnRH reduced at the midcycle surge in the human? Evidence from a GnRH-deficient model.
    Martin KA, Welt CK, Taylor AE, Smith JA, Crowley WF, Hall JE.
    Neuroendocrinology; 1998 Jun; 67(6):363-9. PubMed ID: 9662715
    [Abstract] [Full Text] [Related]

  • 16. Corpus luteum insufficiency induced by a rapid gonadotropin-releasing hormone-induced gonadotropin secretion pattern in the follicular phase.
    Soules MR, Clifton DK, Bremner WJ, Steiner RA.
    J Clin Endocrinol Metab; 1987 Sep; 65(3):457-64. PubMed ID: 3114301
    [Abstract] [Full Text] [Related]

  • 17. Benefits of continuous physiological pulsatile gonadotropin-releasing hormone therapy in women with polycystic ovarian syndrome.
    Corenthal L, Von Hagen S, Larkins D, Ibrahim J, Santoro N.
    Fertil Steril; 1994 Jun; 61(6):1027-33. PubMed ID: 8194612
    [Abstract] [Full Text] [Related]

  • 18. The rhesus monkey corpus luteum is dependent on pituitary gonadotropin secretion throughout the luteal phase of the menstrual cycle.
    Hutchison JS, Zeleznik AJ.
    Endocrinology; 1984 Nov; 115(5):1780-6. PubMed ID: 6436009
    [Abstract] [Full Text] [Related]

  • 19. Ovulation induction using s.c. pulsatile gonadotrophin-releasing hormone: effectiveness of different pulse frequencies.
    Letterie GS, Coddington CC, Collins RL, Merriam GR.
    Hum Reprod; 1996 Jan; 11(1):19-22. PubMed ID: 8671151
    [Abstract] [Full Text] [Related]

  • 20. The treatment of luteal phase defects with pulsatile infusion of gonadotropin-releasing hormone.
    Loucopoulos A, Ferin M.
    Fertil Steril; 1987 Dec; 48(6):933-6. PubMed ID: 3119374
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.